ABERA BIOSCIENCE AB (8WK) — Cash Flow-to-Debt Ratio
ABERA BIOSCIENCE AB (8WK) has a Cash Flow-to-Debt Ratio of -0.09x as of December 2025, meaning its operating cash flow of €-815.00K could theoretically repay 0% of its total liabilities (€9.28 Million) in one year. See ABERA BIOSCIENCE AB free cash flow efficiency to measure how efficiently the company converts operating cash flow to free cash.
CF-to-Debt Ratio
Operating Cash Flow
Total Liabilities
Data as of
ABERA BIOSCIENCE AB Cash Flow-to-Debt Ratio (2022–2025)
Historical debt coverage capacity for ABERA BIOSCIENCE AB across 4 annual periods. Also explore net asset growth rate of ABERA BIOSCIENCE AB to track the company's year-over-year net asset growth rate.
Annual Cash Flow-to-Debt Ratio for ABERA BIOSCIENCE AB (2022–2025)
Year-by-year debt coverage analysis for ABERA BIOSCIENCE AB. For market capitalisation and broader financial context, see ABERA BIOSCIENCE AB market capitalisation.
| Year | CF-to-Debt Ratio | Operating CF (EUR) | Total Liabilities | YoY Change |
|---|---|---|---|---|
| 2025 | -0.35x | €-3.26 Million | €9.28 Million | ▼ -777.2% |
| 2024 | -0.04x | €-198.00K | €4.95 Million | ▲ +99.2% |
| 2023 | -4.80x | €-17.71 Million | €3.69 Million | ▲ +31.9% |
| 2022 | -7.05x | €-19.69 Million | €2.80 Million | — |